Sign In
Buy LQDA
$71.21
-6.72 (-8.62%)
At Close: Jul 13, 2026
A Look at Liquidia Corp (LQDA) After 8.7% Decline -- GF Value $232.05 vs Price $71.22
08:29pm, Monday, 13'th Jul 2026
On July 13, 2026, Liquidia Corp (LQDA) shares experienced a notable decline of 8.7%, currently priced at $71.22. This price movement comes amidst a 52-week rang
Can LQDA's Yutrepia Drive Growth in the Competitive PAH Market?
01:40pm, Monday, 13'th Jul 2026
LQDA's Yutrepia posts a strong commercial debut, but sustaining growth will hinge on standing out in the crowded PAH market as competition intensifies.
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
12:17pm, Friday, 10'th Jul 2026
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.
LQDA Stock Soars 129.7% YTD: Is There More Room for Growth?
01:25pm, Tuesday, 07'th Jul 2026
Liquidia has surged 129.7% so far in 2026 as Yutrepia gains traction, driving strong sales, profitability and higher earnings estimates.
Liquidia Corporation (LQDA) Is Up 9.99% in One Week: What You Should Know
01:00pm, Friday, 03'rd Jul 2026
Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can Yutrepia Maintain Momentum for LQDA Stock in 2026?
03:16pm, Thursday, 02'nd Jul 2026
LQDA's Yutrepia launch is gaining traction, with $130 million in Q1 sales, rising prescriptions and profitability as the company expands in PAH.
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
08:49am, Monday, 29'th Jun 2026
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
3 Best Low-Beta Stocks to Buy Right Away: LQDA, FLXS & AGX
09:05am, Tuesday, 23'rd Jun 2026
LQDA, FLXS and AGX screen as low-beta stocks with positive price moves, solid trading volume and company-specific growth drivers amid market fears.
Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript
06:22pm, Tuesday, 16'th Jun 2026
Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?
04:42pm, Monday, 15'th Jun 2026
Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
08:30am, Thursday, 11'th Jun 2026
MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challengi
Liquidia Corp (LQDA) Stock Up 3.4% and Still Undervalued -- GF Score: 75/100
07:24pm, Monday, 08'th Jun 2026
On June 08, 2026, Liquidia Corp (LQDA) shares rose 3.4% today, continuing a strong performance within a 52-week range of $11.85 to $66.78. The stock has shown i
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
08:30am, Monday, 08'th Jun 2026
MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challengi
4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO
12:15pm, Friday, 05'th Jun 2026
Fragile Iran ceasefire keeps stocks volatile. Low-beta picks LQDA, CVX, OXY and VLO show recent gains and solid volume.
4 Biotech Stocks Investors Should Watch in 2026
11:55am, Friday, 05'th Jun 2026
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
